FENC logo

Fennec Pharmaceuticals (FENC)

Profile

Full Name

Fennec Pharmaceuticals Inc.

Ticker Symbol

FENC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 15, 2017

Indexes

Not included

Website

http://www.fennecpharma.com

Employees

32

Key Details

Price

$5.27(+5.19%)

Market cap

$145.42M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$47.54M(+123.69% YoY)

Annual EPS

-$0.02(+96.67% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.27
FENC price is $5.27

30-Day Relative Volume

0.46
FENC 30-day relative volume is 0.46

Price Performance

Price Most recent change

+5.19%
FENC price was up +5.19% on Apr 14, 2025

Price YTD change

-16.61%
FENC price is down -16.61% since January 1st

Price 1-year change

-49.76%
FENC price is down -49.76% year-on-year

Price 3-year change

-15%
FENC price is down -15% over the past 3 years

Price Range

Price All-time high

$14.99
FENC price is currently -64.83% below its historical high of $14.99

Price 3-year low

$3.96
FENC price is currently +33.08% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$145.42M
FENC market capitalization is $145.42 million

Market cap 3-year change

-9.93%
FENC market capitalization is down -9.93% over the past 3 years

Market cap All-time high

$338.00M
FENC market capitalization is currently -56.98% below its historical high of $338.00 million

Market cap sector rank

52.83%
FENC market capitalization is higher than 52.83% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.8%
FENC shares outstanding is up +1.8% year-on-year

Shares Outstanding 3-Year Change

+5.97%
FENC shares outstanding is up +5.97% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.65
FENC beta is 0.65

200-day SMA

$5.74
FENC price is currently -8.23% below its 200-day simple moving average

50-day SMA

$6.34
FENC price is currently -16.87% below its 50-day simple moving average

RSI

37.52
FENC 14-day relative strength index is 37.52

Volume

0.46
FENC 30-day relative volume is 0.46

ATR

$0.40
FENC average true range is $0.40

10-day Historical Volatility

81.66%
FENC 10-day historical volatility is 81.66%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$47.54M
FENC annual revenue is $47.54 million

Revenue Analysts estimate

$47.86M
FENC annual revenue is currently -0.66% lower than the consensus analysts' forecast

Revenue 1-year change

+123.69%
FENC annual revenue is up +123.69% year-on-year

Revenue Sector rank

45.8%
FENC annual revenue is higher than 45.8% of companies in Healthcare sector

EPS

EPS

-$0.02
FENC annual earnings per share is -$0.02

EPS Analysts estimate

-$0.05
FENC annual earnings per share is currently -61.90% lower than the consensus analysts' forecast

EPS 1-year change

+96.67%
FENC annual earnings per share is up +96.67% year-on-year

EPS Sector rank

81.8%
FENC annual earnings per share is higher than 81.8% of companies in Healthcare sector

Profit

Gross profit

$44.35M
FENC annual gross profit is $44.35 million

Gross margin

93.30%
FENC annual gross profit margin is 93.30%

Operating profit

$2.57M
FENC annual operating income is $2.57 million

Operating margin

5.40%
FENC annual operating profit margin is 5.40%

Net income

-$436.00K
FENC annual net profit is -$436.00 thousand

Net margin

-0.92%
FENC annual net profit margin is -0.92%

Expenses

Total expenses

$44.97M
FENC annual total expenses is $44.97 million

Operating expenses

$41.79M
FENC annual total operating expenses is $41.79 million

Cost of goods sold

$3.18M
FENC annual cost of goods sold is $3.18 million

Selling, general & administrative expenses

$41.48M
FENC annual SGA is $41.48 million

Depreciation and amortization

$800.00K
FENC annual depreciation & amortization is $800.00 thousand

Interest expense

$4.07M
FENC annual interest expense is $4.07 million

Income tax

$365.00K
FENC annual income tax is $365.00 thousand

EBIT & EBITDA

EBIT

$4.00M
FENC annual earnings before interest & taxes is $4.00 million

EBITDA

$4.00M
FENC annual EBITDA is $4.00 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$44.95M
FENC annual total assets is $44.95 million

Non current assets

$924.00K
FENC annual long term assets is $924.00 thousand

Current assets

$44.02M
FENC annual total current assets is $44.02 million

Cash and cash equivalents

$26.63M
FENC annual cash & cash equivalents is $26.63 million

Accounts receivable

$12.88M
FENC annual accounts receivable is $12.88 million

Inventory

$1.06M
FENC annual inventory is $1.06 million

Liabilities

Total liabilities

$50.82M
FENC annual total liabilities is $50.82 million

Long term liabilities

$43.90M
FENC annual total long term liabilities is $43.90 million

Current liabilities

$6.55M
FENC annual total current liabilities is $6.55 million

Accounts payable

$3.24M
FENC annual accounts payable is $3.24 million

Debt

Total debt

$19.34M
FENC annual total debt is $19.34 million

Total debt 1-year change

-37.52%
FENC annual total debt is down -37.52% year-on-year

Long term debt

$19.34M
FENC annual long term debt is $19.34 million

Short term debt

$2000.00
FENC annual short term debt is $2000.00

Equity & Capital

Shareholders equity

-$5.87M
FENC annual stockholders equity is -$5.87 million

Book value

-$5.51M
FENC annual book value is -$5.51 million

Retained earnings

-$219.31M
FENC annual retained earnings is -$219.31 million

Working capital

$37.47M
FENC annual working capital is $37.47 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$26.98M
FENC annual cash flow from operations is $26.98 million

Cash from operations 1-year change

+257.38%
FENC annual cash flow from operations is up +257.38% year-on-year

Cash from investing

-
FENC annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
FENC annual cash flow from investing activities 1-year change is unknown

Cash from financing

-$13.62M
FENC annual cash flow from financing activities is -$13.62 million

Cash from financing 1-year change

-305.11%
FENC annual cash flow from financing activities is down -305.11% year-on-year

CAPEX

CAPEX

-
FENC annual capital expenditures value is unknown

CAPEX 1-year change

-
FENC annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

$26.98M
FENC annual free cash flow is $26.98 million

Free cash flow 1-year change

+257.38%
FENC annual free cash flow is up +257.38% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

93.30%
FENC annual gross profit margin is 93.30%

Operating margin

5.40%
FENC annual operating profit margin is 5.40%

Net margin

-0.92%
FENC annual net profit margin is -0.92%

ROA & ROE

ROA

-1.21%
FENC annual return on assets is -1.21%

ROE

7.43%
FENC annual return on equity is 7.43%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
FENC price to earnings ratio value is unknown

PE ratio Sector rank

-
FENC price to earnings ratio is unknown

PB Ratio

PB ratio

-24.77
FENC price to book ratio is -24.77

PB ratio Sector rank

1.32%
FENC price to book ratio is higher than 1.32% of companies in Healthcare sector

PS Ratio

PS ratio

3.06
FENC price to sales ratio is 3.06

PS ratio Sector rank

52.31%
FENC price to sales ratio is higher than 52.31% of companies in Healthcare sector

Enterprise value

Enterprise value

$138.13M
FENC enterprise value is $138.13 million

Enterprise value Sector rank

53.18%
FENC enterprise value is higher than 53.18% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

28.94
FENC EV/EBITDA is 28.94

EV/EBITDA Sector rank

94.53%
FENC EV/EBITDA is higher than 94.53% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.72
FENC annual current ratio is 6.72

Quick ratio

6.56
FENC annual quick ratio is 6.56

Leverage

Debt to equity

-3.51
FENC annual debt to equity ratio is -3.51

Interest coverage ratio

0.98
FENC annual interest coverage ratio is 0.98

Risk & Stability

Piotroski F-Score

4
FENC piotroski f-score is 4

Altman Z-Score

-2.76
FENC altman z-score is -2.76

Analyst ratings

Recent major analysts updates

Mar 11, 25 HC Wainwright & Co.
Buy
Dec 17, 24 HC Wainwright & Co.
Buy
Aug 22, 24 HC Wainwright & Co.
Buy
Aug 14, 24 Craig-Hallum
Buy
May 15, 24 HC Wainwright & Co.
Buy
May 15, 24 Craig-Hallum
Buy
Apr 4, 24 HC Wainwright & Co.
Buy
Mar 18, 24 Craig-Hallum
Buy
Aug 4, 23 HC Wainwright & Co.
Buy
Jun 21, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

PBYI logo
Puma Biotechnology (PBYI)
TNGX logo
Tango Therapeutics (TNGX)
PROF logo
Profound Medical (PROF)
DERM logo
Journey Medical (DERM)
MOLN logo
Molecular Partners AG (MOLN)
IKT logo
Inhibikase Therapeutics (IKT)
CLLS logo
Cellectis SA (CLLS)
American Oncology Network (AONC)
STXS logo
Stereotaxis (STXS)
  • What is the ticker symbol for Fennec Pharmaceuticals?
  • Does Fennec Pharmaceuticals pay dividends?
  • What sector is Fennec Pharmaceuticals in?
  • What industry is Fennec Pharmaceuticals in?
  • What country is Fennec Pharmaceuticals based in?
  • When did Fennec Pharmaceuticals go public?
  • Is Fennec Pharmaceuticals in the S&P 500?
  • Is Fennec Pharmaceuticals in the NASDAQ 100?
  • Is Fennec Pharmaceuticals in the Dow Jones?
  • When was Fennec Pharmaceuticals's last earnings report?
  • When does Fennec Pharmaceuticals report earnings?
  • Should I buy Fennec Pharmaceuticals stock now?

What is the ticker symbol for Fennec Pharmaceuticals?

The ticker symbol for Fennec Pharmaceuticals is NASDAQ:FENC

Does Fennec Pharmaceuticals pay dividends?

No, Fennec Pharmaceuticals does not pay dividends

What sector is Fennec Pharmaceuticals in?

Fennec Pharmaceuticals is in the Healthcare sector

What industry is Fennec Pharmaceuticals in?

Fennec Pharmaceuticals is in the Biotechnology industry

What country is Fennec Pharmaceuticals based in?

Fennec Pharmaceuticals is headquartered in United States

When did Fennec Pharmaceuticals go public?

Fennec Pharmaceuticals's initial public offering (IPO) was on September 15, 2017

Is Fennec Pharmaceuticals in the S&P 500?

No, Fennec Pharmaceuticals is not included in the S&P 500 index

Is Fennec Pharmaceuticals in the NASDAQ 100?

No, Fennec Pharmaceuticals is not included in the NASDAQ 100 index

Is Fennec Pharmaceuticals in the Dow Jones?

No, Fennec Pharmaceuticals is not included in the Dow Jones index

When was Fennec Pharmaceuticals's last earnings report?

Fennec Pharmaceuticals's most recent earnings report was on Mar 10, 2025

When does Fennec Pharmaceuticals report earnings?

The next expected earnings date for Fennec Pharmaceuticals is May 14, 2025

Should I buy Fennec Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page